1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,024 | 0,026 | 15.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.06. | Genflow Biosciences PLC Announces Notice of AGM | 403 | ACCESS Newswire | Notice of Annual General Meeting and Board Changes LONDON, UK / ACCESS Newswire / June 4, 2026 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the... ► Artikel lesen | |
| 04.06. | Genflow Biosciences - Notice of AGM | 1 | RNS | ||
| 08.05. | Genflow Biosciences PLC Announces Exercise of Warrants and Issue of Equity | 349 | ACCESS Newswire | THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018... ► Artikel lesen | |
| GENFLOW BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 08.05. | Genflow Biosciences - Exercise of Warrants and Issue of Equity | 2 | RNS | ||
| 30.04. | Genflow Biosciences PLC Announces Final Results | 182 | ACCESS Newswire | THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK... ► Artikel lesen | |
| 30.04. | Genflow Biosciences - Final Results | 4 | RNS | ||
| 28.04. | Genflow Biosciences PLC Announces Expansion of Confidentiality Agreements | 192 | ACCESS Newswire | THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK... ► Artikel lesen | |
| 28.04. | Genflow Biosciences - Expansion of Confidentiality Agreements | 1 | RNS | ||
| 20.04. | Genflow kooperiert mit Acuitas bei Technologie zur Verabreichung von Gentherapien | 1 | Investing.com Deutsch | ||
| 20.04. | Genflow partners with Acuitas for gene therapy delivery tech | 4 | Investing.com | ||
| 20.04. | Genflow Biosciences PLC Announces Strategic Technology Collaboration | 273 | ACCESS Newswire | Genflow Biosciences Enters Strategic Technology Collaboration with Acuitas Therapeutics - Fully Funded, Non-Dilutive Access to World-Class LNP Delivery Platform LONDON, UK / ACCESS Newswire / April... ► Artikel lesen | |
| 20.04. | Genflow Biosciences - Strategic Technology Collaboration | - | RNS | ||
| 13.04. | Genflow expands patent coverage to muscular disease treatments | 4 | Investing.com | ||
| 13.04. | Genflow Biosciences PLC Announces International Patent Publication | 311 | ACCESS Newswire | THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK... ► Artikel lesen | |
| 13.04. | Genflow Biosciences - International Patent Publication | 2 | RNS | ||
| 08.04. | Genflow reports sustained safety in aged dog gene therapy trial | 3 | Investing.com | ||
| 08.04. | Genflow Biosciences - Update on the Dog Study | - | RNS | ||
| 31.03. | Genflow Biosciences PLC Announces Total Voting Rights | 245 | ACCESS Newswire | LONDON, UK / ACCESS Newswire / March 31, 2026 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") announces that the total issued share capital of the Company as at 31 March... ► Artikel lesen | |
| 31.03. | Genflow Biosciences - Total Voting Rights | 2 | RNS | ||
| 05.03. | Genflow Biosciences PLC Announces Issue of Equity & PDMR Notifications | 280 | ACCESS Newswire | THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK... ► Artikel lesen |
1 2 3 4 Weiter >>
62 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDIGENE | 0,020 | -8,18 % | PTA-Adhoc: Medigene AG: Widerruf der Zulassung der Aktien der Medigene AG zum Handel im regulierten Markt | DJ PTA-Adhoc: Medigene AG: Widerruf der Zulassung der Aktien der Medigene AG zum Handel im regulierten Markt
Veröffentlichung von Insiderinformationen gemäß Artikel 17 MAR Schlagwort(e): Sonstiges... ► Artikel lesen | |
| CRISPR THERAPEUTICS | 44,975 | -0,91 % | Citizens reiterates CRISPR Therapeutics stock rating on Casgevy data | ||
| CO.DON | 0,016 | -32,61 % | EQS-AFR: CO.DON AG i.l.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: CO.DON AG i.l.
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
CO.DON AG i.l.: Vorabbekanntmachung über die... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 24.04.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.04.2026.ISIN NameCA46658Y1034 J2... ► Artikel lesen | |
| PACIFIC BIOSCIENCES OF CALIFORNIA | 1,175 | +3,52 % | Druck auf Pacific Biosciences nimmt zu: Warum die Geduld der Anleger auf eine harte Probe gestellt wird | Pacific Biosciences gerät zunehmend unter Druck: Die Aktie steht nach einer "significant downward revision of revenue guidance" und dem erzwungenen Aktienrückzug eines Großaktionärs im Fokus. Für Investoren... ► Artikel lesen | |
| TME PHARMA | 0,084 | +3,57 % | TME Pharma NV: TME Pharma publishes its annual financial results and annual report | TME Pharma publishes its annual financial results and annual report Berlin, Germany, April 30, 2026, 20.00am CET - TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company... ► Artikel lesen | |
| DENALI THERAPEUTICS | 19,200 | +0,08 % | Biogen And Denali Stop BIIB122 Development After Phase 2b Parkinson's Trial Shows No Benefit | WESTON (dpa-AFX) - Biogen Inc. (BIIB) and Denali Therapeutics Inc. (DNLI) reported results from the Phase 2b LUMA study evaluating BIIB122 (DNL151), a small molecule inhibitor of LRRK2 in early-stage... ► Artikel lesen | |
| REPLENISH NUTRIENTS | 0,071 | -2,74 % | Replenish Nutrients to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub | ||
| GLOW LIFETECH | 0,026 | 0,00 % | Glow Lifetech Corp.: Glow Lifetech Achieves Warrant-Free Capital Structure Following Elimination of 70 Million Warrants and 20% Reduction in Fully Diluted Shares | Toronto, Ontario--(Newsfile Corp. - June 2, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that all of its outstanding 8,900,000... ► Artikel lesen | |
| VOYAGER THERAPEUTICS | 3,170 | +1,02 % | Voyager Therapeutics, Inc. - 8-K, Current Report | ||
| NEOVACS | 0,000 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.05.2026 | Das Instrument POH3 US14365C1036 CARNIVAL PLC ADR/1 DL1,66 EQUITY wird cum Kapitalmassnahme gehandelt am 06.05.2026 und ex Kapitalmassnahme am 07.05.2026 The instrument POH3 US14365C1036 CARNIVAL PLC... ► Artikel lesen | |
| BIOAGE LABS | 16,760 | -2,27 % | BioAge Labs, Inc. - 8-K, Current Report | ||
| BIOVAXYS TECHNOLOGY | 0,044 | -100,00 % | CSE Bulletin: Suspensions - VSBLTY Groupe Technologies Corp., NuRAN Wireless Inc., GOAT Industries Ltd., BYT Holdings Ltd., ASEP Medical Holdings Inc., BioVaxys Technology Corp. | Le 6 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading... ► Artikel lesen | |
| NANOSPHERE HEALTH SCIENCES | 0,008 | 0,00 % | Nanosphere Health Sciences Inc (2): Nanosphere Health adopts semi-annual reporting | ||
| TELO GENOMICS | 0,034 | 0,00 % | Telo Genomics Corp.: Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma | Vancouver, British Columbia--(Newsfile Corp. - April 14, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and... ► Artikel lesen |
GENFLOW BIOSCIENCES PLC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von -0,001 (-2,13 %) liegt der Kurs bei 0,023 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GENFLOW BIOSCIENCES PLC finden Sie auf Wallstreet Online.